PrP turnover in vivo and the time to effect of prion disease therapeutics.
Corridon TL, O'Moore J, Lian Y, Laversenne V, Noble B, Kamath NG, Serack FE, Shaikh AB, Erickson B, Braun C, Lenz K, Howard M, Chan N, Reidenbach AG, Cabin DE, Vallabh SM, Grindeland A, Oberbeck N, Zhao HT, Minikel EV.
Corridon TL, et al. Among authors: grindeland a.
bioRxiv [Preprint]. 2024 Nov 14:2024.11.12.623215. doi: 10.1101/2024.11.12.623215.
bioRxiv. 2024.
PMID: 39605733
Free PMC article.
Preprint.